Home › Funds › KCM Capital Inc › ABT
KCM Capital Inc position in ABT
ABBOTT LABORATORIES · Health Care
KCM Capital Inc reported holding 38,127 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.56% of its reported portfolio and ranking #32 among its reported holdings. KCM Capital Inc has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How KCM Capital Inc's ABT position evolved
KCM Capital Inc first disclosed a stake in ABT in Q4 2025 at 38,128 shares (US$4.8M). Across 4 filings, KCM Capital Inc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 38,127 shares valued at US$3.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 38.13K | $4.78M | New |
| Q1 2026 | 38.13K | $3.91M | Hold |
| Q2 2026 | 38.13K | $3.46M | Hold |
| Q3 2026 | 38.13K | $3.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 44.98M sh · $4.45B · Q3 2026
- Capital International Investors 35.46M sh · $3.51B · Q3 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Franklin Resources 20.44M sh · $2.36B · Q3 2026
- Deutsche Bank AG 17.69M sh · $1.75B · Q3 2026
- MFS Investment Management 14.93M sh · $1.48B · Q3 2026
More on KCM Capital Inc
FAQ
How long has KCM Capital Inc held ABT?
KCM Capital Inc has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is KCM Capital Inc's current position in ABT?
As of Q3 2026, KCM Capital Inc holds 38.13K shares of ABT (ABBOTT LABORATORIES), valued at $3.77M, representing 0.56% of its reported portfolio and ranking #32.
Has KCM Capital Inc been buying or selling ABT?
In the latest 13F filing (Q3 2026), KCM Capital Inc held unchanged its position in ABT.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.